{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:24:23Z","timestamp":1791404663799,"version":"4.3.3"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"crossref","award":["R21NS133895-01"],"award-info":[{"award-number":["R21NS133895-01"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"crossref","award":["R01NS105787"],"award-info":[{"award-number":["R01NS105787"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>As a key inflammatory factor, the nucleotide-binding oligomerization domain (NOD)-like receptor protein 3 (NLRP3) inflammasome plays a crucial role in neuroinflammation and the progression of neurodegenerative diseases. Dysregulation of NLRP3 signaling can trigger various inflammatory responses in the brain, contributing to the development of neurodegenerative diseases such as ischemic stroke, vascular dementia (VaD), Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD), and amyotrophic lateral sclerosis (ALS). Therefore, the NLRP3 signaling pathway is a promising therapeutic target for the treatment of neurodegenerative diseases, including VaD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we investigated the therapeutic effects of a synthetic sulfonylurea NLRP3 inhibitor, AMS-17, in a VaD mouse model using bilateral common carotid artery stenosis (BCAS) and elucidated the underlying mechanisms. All mice were randomly divided into three groups: Sham, VaD\u2009+\u2009Vehicle, and VaD\u2009+\u2009AMS-17. Cognitive function was assessed using the Y-maze and Morris water maze (MWM) on the 50th day after BCAS. Brain sections and blood serum samples were collected for biomarker analysis and immunohistochemistry. Neurodegeneration, expressions of the molecules involved in the NLRP3 signaling pathways, tight junction proteins, and myelination were assessed using western blotting and immunofluorescence (IF). The levels of Interleukin-1 beta (IL-1\u03b2), Tumor Necrosis Factor-alpha (TNF-\u03b1) and Interleukin-4 (IL-4) in the blood were measured using ELISA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>AMS-17 treatment improved cognitive function, enhanced blood-brain barrier (BBB) integrity, and promoted remyelination in VaD mice. Additionally, AMS-17 reduced neurodegeneration and decreased the expression of NLRP3 and its associated proteins, Apoptosis-associated speck-like protein (ASC), and cleaved caspase-1 in the brain. It also lowered pro-inflammatory TNF-\u03b1 and IL-1\u03b2 levels, while increasing the anti-inflammatory IL-4 level in the blood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The findings of this study provide the first promising evidence for the use of AMS-17 in VaD treatment in mice. This study introduces AMS-17 as a novel chemical scaffold with NLRP3 inhibitory activity, which can be further developed for the treatment of VaD in humans.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s12987-025-00665-6","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T05:00:10Z","timestamp":1748926810000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Targeting NLRP3 signaling with a novel sulfonylurea compound for the treatment of vascular cognitive impairment and dementia"],"prefix":"10.1186","volume":"22","author":[{"given":"Adnan","family":"Akif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Thanh My","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Langni","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amol","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiukuan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"665_CR1","doi-asserted-by":"crossref","unstructured":"Fitzpatrick AL, Kuller LH, Lopez OL, Kawas CH, Jagust W. Survival following dementia onset: Alzheimer\u2019s disease and vascular dementia. J Neurol Sci [Internet]. 2005 Mar 15 [cited 2023 Jan 30];229:43\u20139. Available from: https:\/\/www.jns-journal.com\/article\/S0022-510X(04)00445-9\/fulltext","DOI":"10.1016\/j.jns.2004.11.022"},{"key":"665_CR2","doi-asserted-by":"crossref","unstructured":"Belkhelfa M, Beder N, Mouhoub D, Amri M, Hayet R, Tighilt N et al. The involvement of neuroinflammation and necroptosis in the hippocampus during vascular dementia. J Neuroimmunol [Internet]. 2018 Jul 15 [cited 2023 Jan 30];320:48\u201357. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0165572818300316","DOI":"10.1016\/j.jneuroim.2018.04.004"},{"issue":"1","key":"665_CR3","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s12035-021-02612-6","volume":"59","author":"R Dhapola","year":"2022","unstructured":"Dhapola R, Sarma P, Medhi B, Prakash A, Reddy DH. Recent advances in molecular pathways and therapeutic implications targeting mitochondrial dysfunction for Alzheimer\u2019s disease. Mol Neurobiol. 2022;59(1):535\u201355.","journal-title":"Mol Neurobiol"},{"key":"665_CR4","doi-asserted-by":"crossref","unstructured":"Bai R, Lang Y, Shao J, Deng Y, Refuhati R, Cui L. The Role of NLRP3 Inflammasome in Cerebrovascular Diseases Pathology and Possible Therapeutic Targets. ASN NEURO [Internet]. 2021 May 29 [cited 2024 Nov 24];13:17590914211018100. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8168029\/","DOI":"10.1177\/17590914211018100"},{"issue":"7734","key":"665_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-018-0761-3","volume":"564","author":"J Chen","year":"2018","unstructured":"Chen J, Chen ZJ. PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation. Nature. 2018;564(7734):71\u20136.","journal-title":"Nature"},{"issue":"4","key":"665_CR6","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1161\/ATVBAHA.117.310581","volume":"38","author":"T Karasawa","year":"2018","unstructured":"Karasawa T, Kawashima A, Usui-Kawanishi F, Watanabe S, Kimura H, Kamata R, et al. Saturated fatty acids undergo intracellular crystallization and activate the NLRP3 inflammasome in macrophages. Arterioscler Thromb Vasc Biol. 2018;38(4):744\u201356.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"665_CR7","doi-asserted-by":"publisher","unstructured":"Li Y, Chen X, Zhou M, Feng S, Peng X, Wang Y. Microglial TLR4\/NLRP3 Inflammasome Signaling in Alzheimer\u2019s Disease. J Alzheimer\u2019s Dis [Internet]. 2024 Jan 1 [cited 2024 Nov 24];97(1):75\u201388. Available from: https:\/\/journals.sagepub.com\/doi\/abs\/https:\/\/doi.org\/10.3233\/JAD-230273","DOI":"10.3233\/JAD-230273"},{"key":"665_CR8","doi-asserted-by":"crossref","unstructured":"Song M, Jin J, Lim JE, Kou J, Pattanayak A, Rehman JA et al. TLR4 mutation reduces microglial activation, increases Ab deposits and exacerbates cognitive deficits in a mouse model of Alzheimer\u2019s disease. 2011.","DOI":"10.1186\/1742-2094-8-92"},{"key":"665_CR9","doi-asserted-by":"publisher","unstructured":"Yang J, Wise L, Fukuchi K. ichiro. TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer\u2019s Disease. Front Immunol [Internet]. 2020 Apr 23 [cited 2023 Sep 24];11:724. Available from: https:\/\/www.frontiersin.org\/article\/https:\/\/doi.org\/10.3389\/fimmu.2020.00724\/full","DOI":"10.3389\/fimmu.2020.00724\/full"},{"key":"665_CR10","doi-asserted-by":"crossref","unstructured":"Liu Y, Chen X, Gong Q, Shi J, Li F. Osthole Improves Cognitive Function of Vascular Dementia Rats: Reducing A\u03b2 Deposition via Inhibition NLRP3 Inflammasome. Biol Pharm Bull [Internet]. 2020 Sep 1 [cited 2023 Jan 30];43(9):1315\u201323. Available from: https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/9\/43_b20-00112\/_article","DOI":"10.1248\/bpb.b20-00112"},{"key":"665_CR11","doi-asserted-by":"crossref","unstructured":"Ward R, Li W, Abdul Y, Jackson L, Dong G, Jamil S et al. NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia. Pharmacol Res [Internet]. 2019 Apr 1 [cited 2024 Nov 24];142:237\u201350. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1043661818310442","DOI":"10.1016\/j.phrs.2019.01.035"},{"key":"665_CR12","doi-asserted-by":"publisher","unstructured":"Chang YP, Ka SM, Hsu WH, Chen A, Chao LK, Lin CC et al. Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagy. J Cell Physiol [Internet]. 2015 [cited 2023 Jan 30];230(7):1567\u201379. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/https:\/\/doi.org\/10.1002\/jcp.24903","DOI":"10.1002\/jcp.24903"},{"key":"665_CR13","doi-asserted-by":"publisher","unstructured":"Honda H, Nagai Y, Matsunaga T, Okamoto N, Watanabe Y, Tsuneyama K et al. Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation. J Leukoc Biol [Internet]. 2014 [cited 2023 Jan 30];96(6):1087\u2013100. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/https:\/\/doi.org\/10.1189\/jlb.3A0114-005RR","DOI":"10.1189\/jlb.3A0114-005RR"},{"key":"665_CR14","doi-asserted-by":"publisher","unstructured":"Yin H, Guo Q, Li X, Tang T, Li C, Wang H et al. Curcumin Suppresses IL-1\u03b2 Secretion and Prevents Inflammation through Inhibition of the NLRP3 Inflammasome. J Immunol [Internet]. 2018 Apr 15 [cited 2023 Jan 30];200(8):2835\u201346. Available from: https:\/\/doi.org\/10.4049\/jimmunol.1701495","DOI":"10.4049\/jimmunol.1701495"},{"key":"665_CR15","doi-asserted-by":"publisher","unstructured":"Baell JB. Feeling Nature\u2019s PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS). J Nat Prod [Internet]. 2016 Mar 25 [cited 2023 Jan 30];79(3):616\u201328. Available from: https:\/\/doi.org\/10.1021\/acs.jnatprod.5b00947","DOI":"10.1021\/acs.jnatprod.5b00947"},{"key":"665_CR16","doi-asserted-by":"crossref","unstructured":"Barczuk J, Siwecka N, Lusa W, Rozp\u0119dek-Kami\u0144ska W, Kucharska E, Majsterek I. Targeting NLRP3-Mediated Neuroinflammation in Alzheimer\u2019s Disease Treatment. Int J Mol Sci [Internet]. 2022 Aug 11 [cited 2024 Mar 17];23(16):8979. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9409081\/","DOI":"10.3390\/ijms23168979"},{"key":"665_CR17","doi-asserted-by":"publisher","unstructured":"Oronsky B, Guo X, Wang X, Cabrales P, Sher D, Cannizzo L et al. Discovery of RRx-001, a Myc and CD47 Downregulating Small Molecule with Tumor Targeted Cytotoxicity and Healthy Tissue Cytoprotective Properties in Clinical Development. J Med Chem [Internet]. 2021 Jun 10 [cited 2024 Mar 17];64(11):7261\u201371. Available from: https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00599","DOI":"10.1021\/acs.jmedchem.1c00599"},{"issue":"2","key":"665_CR18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/cpdd.1162","volume":"12","author":"DV Parmar","year":"2023","unstructured":"Parmar DV, Kansagra KA, Momin T, Patel HB, Jansari GA, Bhavsar J, et al. Safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral NLRP3 inflammasome inhibitor ZYIL1: First-in-Human phase 1 studies (Single ascending dose and multiple ascending dose). Clin Pharmacol Drug Dev. 2023;12(2):202\u201311.","journal-title":"Clin Pharmacol Drug Dev"},{"key":"665_CR19","unstructured":"Vande Walle L, Lamkanfi M. Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets. Nat Rev Drug Discov [Internet]. 2023 Nov 29 [cited 2024 Jan 2]; Available from: https:\/\/www.nature.com\/articles\/s41573-023-00822-2"},{"key":"665_CR20","doi-asserted-by":"publisher","unstructured":"Kulkarni AA, Sajith AM, Zhang C, Hao J, Bowen JP. Small molecule prevents inflammation in microglia by targeting the NLRP3 inflammasome. J Immunol [Internet]. 2020 May 1 [cited 2023 Jan 30];204(1_Supplement):160.15. Available from: https:\/\/doi.org\/10.4049\/jimmunol.204.Supp.160.15","DOI":"10.4049\/jimmunol.204.Supp.160.15"},{"key":"665_CR21","doi-asserted-by":"crossref","unstructured":"Zhang C, Sajith AM, Xu X, Jiang J, Phillip Bowen J, Kulkarni A et al. Targeting NLRP3 signaling by a novel-designed sulfonylurea compound for inhibition of microglial inflammation. Bioorg Med Chem [Internet]. 2022 Mar [cited 2023 Jan 30];58:116645. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089622000372","DOI":"10.1016\/j.bmc.2022.116645"},{"issue":"1","key":"665_CR22","first-page":"126","volume":"29","author":"AA Kulkarni","year":"2020","unstructured":"Kulkarni AA, Sajith AM, Duarte TT, Tena A, Spencer CT, Bowen JP. Design, synthesis, and screening of sulfonylurea-derived NLRP3 inflammasome inhibitors. Med Chem Res Int J Rapid Commun Des Mech Action Biol Act Agents. 2020;29(1):126\u201335.","journal-title":"Med Chem Res Int J Rapid Commun Des Mech Action Biol Act Agents"},{"issue":"6","key":"665_CR23","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1161\/STROKEAHA.110.581686","volume":"41","author":"K Nishio","year":"2010","unstructured":"Nishio K, Ihara M, Yamasaki N, Kalaria RN, Maki T, Fujita Y, et al. A mouse model characterizing features of vascular dementia with hippocampal atrophy. Stroke. 2010;41(6):1278\u201384.","journal-title":"Stroke"},{"key":"665_CR24","doi-asserted-by":"publisher","unstructured":"Hotaling NA, Jeon J, Wade MB, Luong D, Palmer XL, Bharti K et al. Training to Improve Precision and Accuracy in the Measurement of Fiber Morphology. Mishra YK, editor. PLOS ONE [Internet]. 2016 Dec 1 [cited 2025 Mar 2];11(12):e0167664. Available from: https:\/\/doi.org\/10.1371\/journal.pone.0167664","DOI":"10.1371\/journal.pone.0167664"},{"key":"665_CR25","doi-asserted-by":"crossref","unstructured":"Van Tilborg E, Van Kammen CM, De Theije CGM, Van Meer MPA, Dijkhuizen RM, Nijboer CH. A quantitative method for microstructural analysis of myelinated axons in the injured rodent brain. Sci Rep [Internet]. 2017 Nov 28 [cited 2025 Mar 2];7(1):16492. Available from: https:\/\/www.nature.com\/articles\/s41598-017-16797-1","DOI":"10.1038\/s41598-017-16797-1"},{"issue":"1","key":"665_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12987-021-00255-2","volume":"18","author":"Z Sun","year":"2021","unstructured":"Sun Z, Gao C, Gao D, Sun R, Li W, Wang F, et al. Reduction in pericyte coverage leads to blood-brain barrier dysfunction via endothelial transcytosis following chronic cerebral hypoperfusion. Fluids Barriers CNS. 2021;18(1):21.","journal-title":"Fluids Barriers CNS"},{"key":"665_CR28","doi-asserted-by":"publisher","unstructured":"Toda N, Ayajiki K, Okamura T. Cerebral blood flow regulation by nitric oxide in neurological disorders. Can J Physiol Pharmacol [Internet]. 2009 Aug [cited 2025 Apr 1];87(8):581\u201394. Available from: https:\/\/cdnsciencepub.com\/doi\/abs\/https:\/\/doi.org\/10.1139\/y09-048","DOI":"10.1139\/y09-048"},{"key":"665_CR29","doi-asserted-by":"crossref","unstructured":"Hu S, Pi Q, Luo M, Cheng Z, Liang X, Luo S et al. Contribution of the NLRP3\/IL-1\u03b2 axis to impaired vasodilation in sepsis through facilitation of eNOS proteolysis and the protective role of melatonin. Int Immunopharmacol [Internet]. 2021 Apr 1 [cited 2025 Apr 1];93:107388. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1567576921000242","DOI":"10.1016\/j.intimp.2021.107388"},{"key":"665_CR30","doi-asserted-by":"crossref","unstructured":"An L, Shen Y, Chopp M, Zacharek A, Venkat P, Chen Z et al. Deficiency of Endothelial Nitric Oxide Synthase (eNOS) Exacerbates Brain Damage and Cognitive Deficit in A Mouse Model of Vascular Dementia. Aging Dis [Internet]. 2021 Jun 1 [cited 2025 Apr 1];12(3):732\u201346. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8139201\/","DOI":"10.14336\/AD.2020.0523"},{"key":"665_CR31","doi-asserted-by":"publisher","unstructured":"Pan J, Peng J, Li X, Wang H, Rong X, Peng Y. Transmission of NLRP3-IL-1\u03b2 Signals in Cerebral Ischemia and Reperfusion Injury: from Microglia to Adjacent Neuron and Endothelial Cells via IL-1\u03b2\/IL-1R1\/TRAF6. Mol Neurobiol [Internet]. 2023 Jan 30 [cited 2024 Aug 17]; Available from: https:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s12035-023-03232-y","DOI":"10.1007\/s12035-023-03232-y"},{"issue":"8","key":"665_CR32","doi-asserted-by":"publisher","first-page":"4544","DOI":"10.1038\/s41380-020-00971-5","volume":"26","author":"L Poh","year":"2021","unstructured":"Poh L, Fann DY, Wong P, Lim HM, Foo SL, Kang SW, et al. AIM2 inflammasome mediates hallmark neuropathological alterations and cognitive impairment in a mouse model of vascular dementia. Mol Psychiatry. 2021;26(8):4544\u201360.","journal-title":"Mol Psychiatry"},{"key":"665_CR33","doi-asserted-by":"publisher","unstructured":"Wang R, Yin YX, Mahmood Q, Wang XJ, Gao YP, Gou GJ et al. Calmodulin inhibitor ameliorates cognitive dysfunction via inhibiting nitrosative stress and NLRP3 signaling in mice with bilateral carotid artery stenosis. CNS Neurosci Ther [Internet]. 2017 Oct [cited 2023 Jan 30];23(10):818\u201326. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1111\/cns.12726","DOI":"10.1111\/cns.12726"},{"key":"665_CR34","doi-asserted-by":"publisher","unstructured":"Wang L, Ren W, Wu Q, Liu T, Wei Y, Ding J et al. NLRP3 Inflammasome Activation: A Therapeutic Target for Cerebral Ischemia\u2013Reperfusion Injury. Front Mol Neurosci [Internet]. 2022 May 6 [cited 2024 Jun 26];15:847440. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fnmol.2022.847440\/full","DOI":"10.3389\/fnmol.2022.847440\/full"},{"key":"665_CR35","doi-asserted-by":"crossref","unstructured":"Youm YH, Grant RW, McCabe LR, Albarado DC, Nguyen KY, Ravussin A et al. Canonical Nlrp3 Inflammasome Links Systemic Low-Grade Inflammation to Functional Decline in Aging. Cell Metab [Internet]. 2013 Oct [cited 2024 Jun 26];18(4):519\u201332. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1550413113003793","DOI":"10.1016\/j.cmet.2013.09.010"},{"key":"665_CR36","doi-asserted-by":"publisher","unstructured":"Hase Y, Polvikoski TM, Ihara M, Hase M, Zafar R, Stevenson W et al. Carotid artery disease in post-stroke survivors and effects of enriched environment on stroke pathology in a mouse model of carotid artery stenosis. Neuropathol Appl Neurobiol [Internet]. 2019 Dec [cited 2024 Jun 26];45(7):681\u201397. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1111\/nan.12550","DOI":"10.1111\/nan.12550"},{"key":"665_CR37","doi-asserted-by":"publisher","unstructured":"Yang L, Song J, Nan D, Wan Y, Guo H. Cognitive Impairments and blood-brain Barrier Damage in a Mouse Model of Chronic Cerebral Hypoperfusion. Neurochem Res [Internet]. 2022 Dec 1 [cited 2024 Jun 26];47(12):3817\u201328. Available from: https:\/\/doi.org\/10.1007\/s11064-022-03799-3","DOI":"10.1007\/s11064-022-03799-3"},{"key":"665_CR38","doi-asserted-by":"crossref","unstructured":"Roseborough AD, Zhu Y, Zhao L, Laviolette SR, Pasternak SH, Whitehead SN. Fibrinogen primes the microglial NLRP3 inflammasome and propagates pro-inflammatory signaling via extracellular vesicles: Implications for blood-brain barrier dysfunction. Neurobiol Dis [Internet]. 2023 Feb [cited 2024 Jun 26];177:106001. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996123000153","DOI":"10.1016\/j.nbd.2023.106001"},{"key":"665_CR39","doi-asserted-by":"publisher","unstructured":"Wang Y, Jin S, Sonobe Y, Cheng Y, Horiuchi H, Parajuli B et al. Interleukin-1\u03b2 Induces Blood\u2013Brain Barrier Disruption by Downregulating Sonic Hedgehog in Astrocytes. Kira J ichi, editor. PLoS ONE [Internet]. 2014 Oct 14 [cited 2024 Jun 26];9(10):e110024. Available from: https:\/\/doi.org\/10.1371\/journal.pone.0110024","DOI":"10.1371\/journal.pone.0110024"},{"key":"665_CR40","doi-asserted-by":"crossref","unstructured":"Rock KL, Kono H. The inflammatory response to cell death. Annu Rev Pathol [Internet]. 2008 [cited 2024 Jun 27];3:99\u2013126. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3094097\/","DOI":"10.1146\/annurev.pathmechdis.3.121806.151456"},{"issue":"4","key":"665_CR41","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1365-2990.2007.00828.x","volume":"33","author":"JE Simpson","year":"2007","unstructured":"Simpson JE, Fernando MS, Clark L, Ince PG, Matthews F, Forster G, et al. White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses. Neuropathol Appl Neurobiol. 2007;33(4):410\u20139.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"665_CR42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bbi.2016.09.024","volume":"60","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Zhang J, Wang L, Chen Y, Wan Y, He Y, et al. Interleukin-1\u03b2 impedes oligodendrocyte progenitor cell recruitment and white matter repair following chronic cerebral hypoperfusion. Brain Behav Immun. 2017;60:93\u2013105.","journal-title":"Brain Behav Immun"},{"key":"665_CR43","doi-asserted-by":"publisher","unstructured":"Lee KM, Bang J, Kim BY, Lee IS, Han JS, Hwang BY et al. Fructus mume alleviates chronic cerebral hypoperfusion-induced white matter and hippocampal damage via inhibition of inflammation and downregulation of TLR4 and p38 MAPK signaling. BMC Complement Altern Med [Internet]. 2015 Apr 22 [cited 2024 Jun 27];15(1):125. Available from: https:\/\/doi.org\/10.1186\/s12906-015-0652-1","DOI":"10.1186\/s12906-015-0652-1"},{"issue":"1","key":"665_CR44","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/glia.23190","volume":"66","author":"Y Manso","year":"2018","unstructured":"Manso Y, Holland PR, Kitamura A, Szymkowiak S, Duncombe J, Hennessy E, et al. Minocycline reduces microgliosis and improves subcortical white matter function in a model of cerebral vascular disease. Glia. 2018;66(1):34\u201346.","journal-title":"Glia"},{"issue":"14","key":"665_CR45","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1523\/JNEUROSCI.2451-17.2018","volume":"38","author":"J Miyanohara","year":"2018","unstructured":"Miyanohara J, Kakae M, Nagayasu K, Nakagawa T, Mori Y, Arai K, et al. TRPM2 channel aggravates CNS inflammation and cognitive impairment via activation of microglia in chronic cerebral hypoperfusion. J Neurosci Off J Soc Neurosci. 2018;38(14):3520\u201333.","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"665_CR46","doi-asserted-by":"crossref","unstructured":"Zhao S, Yin J, Zhou L, Yan F, He Q, Huang L et al. Hippo\/MST1 signaling mediates microglial activation following acute cerebral ischemia\u2013reperfusion injury. Brain Behav Immun [Internet]. 2016 Jul 1 [cited 2024 Jun 27];55:236\u201348. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0889159115300787","DOI":"10.1016\/j.bbi.2015.12.016"},{"key":"665_CR47","doi-asserted-by":"publisher","unstructured":"Li C, Jin Y, Wei S, Sun Y, Jiang L, Zhu Q et al. Hippo Signaling Controls NLR Family Pyrin Domain Containing 3 Activation and Governs Immunoregulation of Mesenchymal Stem Cells in Mouse Liver Injury. Hepatology [Internet]. 2019 Nov [cited 2024 Jun 27];70(5):1714\u201331. Available from: https:\/\/journals.lww.com\/https:\/\/doi.org\/10.1002\/hep.30700","DOI":"10.1002\/hep.30700"},{"key":"665_CR48","doi-asserted-by":"publisher","unstructured":"Palomino-Antolin A, Narros\u2010Fern\u00e1ndez P, Farr\u00e9\u2010Alins V, Sevilla\u2010Montero J, Decouty\u2010P\u00e9rez C, Lopez\u2010Rodriguez AB et al. Time\u2010dependent dual effect of NLRP3 inflammasome in brain ischaemia. Br J Pharmacol [Internet]. 2022 Apr [cited 2024 Mar 17];179(7):1395\u2013410. Available from: https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1111\/bph.15732","DOI":"10.1111\/bph.15732"},{"key":"665_CR49","doi-asserted-by":"crossref","unstructured":"Wang H, Shang Y, Wang E, Xu X, Zhang Q, Qian C et al. MST1 mediates neuronal loss and cognitive deficits: A novel therapeutic target for Alzheimer\u2019s disease. Prog Neurobiol [Internet]. 2022 Jul [cited 2024 Aug 17];214:102280. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301008222000661","DOI":"10.1016\/j.pneurobio.2022.102280"},{"issue":"1","key":"665_CR50","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12974-024-03209-1","volume":"21","author":"L Lin","year":"2024","unstructured":"Lin L, Chen Y, He K, Metwally S, Jha R, Capuk O, et al. Carotid artery vascular stenosis causes the blood-CSF barrier damage and neuroinflammation. J Neuroinflammation. 2024;21(1):220.","journal-title":"J Neuroinflammation"},{"key":"665_CR51","doi-asserted-by":"publisher","first-page":"720715","DOI":"10.3389\/fnagi.2021.720715","volume":"13","author":"F Akhter","year":"2021","unstructured":"Akhter F, Persaud A, Zaokari Y, Zhao Z, Zhu D. Vascular dementia and underlying sex differences. Front Aging Neurosci. 2021;13:720715.","journal-title":"Front Aging Neurosci"},{"key":"665_CR52","doi-asserted-by":"publisher","unstructured":"Dong C, Zhou C, Fu C, Hao W, Ozaki A, Shrestha N et al. Sex differences in the association between cardiovascular diseases and dementia subtypes: a prospective analysis of 464,616 UK Biobank participants. Biol Sex Differ [Internet]. 2022 May 7 [cited 2025 Apr 8];13(1):21. Available from: https:\/\/doi.org\/10.1186\/s13293-022-00431-5","DOI":"10.1186\/s13293-022-00431-5"},{"issue":"4","key":"665_CR53","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0197-4580(01)00231-7","volume":"22","author":"A Ruitenberg","year":"2001","unstructured":"Ruitenberg A, Ott A, van Swieten JC, Hofman A, Breteler MM. Incidence of dementia: does gender make a difference? Neurobiol Aging. 2001;22(4):575\u201380.","journal-title":"Neurobiol Aging"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00665-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-025-00665-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00665-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T05:00:17Z","timestamp":1748926817000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-025-00665-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["665"],"URL":"https:\/\/doi.org\/10.1186\/s12987-025-00665-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5611378\/v1","asserted-by":"object"}]},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"assertion":[{"value":"9 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"All animal procedures were approved by the Institutional Animal Care and Use Committees at University of Houston, and they complied with pertinent NIH guidelines for care and use of animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}